arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 9/2019 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Administrative courts block preventive consumer protection

    NEW ON THE MARKET

    Andexanet alfa (ONDEXXYA) – antidote for rivaroxaban and apixaban

    THERAPY FROM A CRITICAL VIEWPOINT

    Breast cancer with postmenopausal hormone treatment

    Ticagrelor or prasugrel in acute coronary syndrome?

    IN BRIEF

    Fremanezumab (AJOVY) in treatment-refractory migraine

    Nitrosamine in all ranitidine preparations?

    CURRENT ADR NETWORK REPORT

    Itraconazole and hypertension
    free

    SIDE EFFECTS

    Trismus with the ADHD drug methylphenidate (RITALIN, generics)

    Vaping illness: FDA warns against tetrahydrocannabinol (THC)-containing liquids for e-cigarettes

    Liver damage with newer combination drugs against hepatitis C

    Life-threatening lung disease with CDK4/6 inhibitors

    e a-t ON THE INTERNET

    Andexanet alfa (ONDEXXYA) – antidote for rivaroxaban and apixaban (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles